← Evolent Health (EVH)

Evolent Health SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • SCHEDULE 13G/ANov. 16, 2026, 3:09 p.m. ETView on SEC.gov
  • SCHEDULE 13G/ANov. 13, 2026, 9:32 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 7:10 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedEvolent Health Q3 2026 revenue of $725.4 million up 51% year over year, adjusted EPS $0.06 in line with consensus; Adjusted EBITDA guidance raised to $130.0-$135.0 million

  • 10-QNov. 5, 2026, 7:05 a.m. ETView on SEC.gov
  • SCHEDULE 13G/ASept. 8, 2026, 5:54 p.m. ETView on SEC.gov
  • 4Aug. 28, 2026, 4:17 p.m. ETView on SEC.gov
  • 10-QAug. 6, 2026, 8:53 a.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 7:03 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits